Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYCR1 | P32322 | 5/20 | 0.55 |
| ▸ | CNR2 | P34972 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29083510 | 0.90 | PYCR1 (0.64) | PYCR1ALDH1A1KDM4EMAOB | |
| SCHEMBL12049793 | 0.87 | CNR2 (0.64) | CNR2TSHRHTTALDH1A1TRPA1 | |
| SCHEMBL6621416 | 0.86 | FNTA (0.54) | PYCR1L3MBTL1ALDH1A1TDP1KDM4E | |
| SCHEMBL134524 | 0.84 | TSHR (0.60) | CNR2TSHRALDH1A1TRPA1TDP1 | |
| SCHEMBL5703578 | 0.82 | PYCR1 (0.58) | PYCR1CNR2TSHRL3MBTL1HTT | |
| SCHEMBL4821913 | 0.82 | CALM1 (0.55) | PYCR1CNR2TSHRL3MBTL1HTT | |
| Ammonia Solution, Strong SCHEMBL1348044 | 0.82 | CNR2 (0.58) | CNR2TSHRALDH1A1TRPA1TDP1 | |
| Bromide SCHEMBL11212819 | 0.82 | CNR2 (0.58) | CNR2TSHRALDH1A1TRPA1TDP1 | |
| Fluoride SCHEMBL633879 | 0.82 | CNR2 (0.58) | CNR2TSHRALDH1A1TRPA1TDP1 | |
| Bromide SCHEMBL6760453 | 0.82 | CNR2 (0.58) | CNR2TSHRALDH1A1TRPA1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10651390-B2 | Tertiary amine compound, photoelectric conversion element, and solar cell | RICOH COMPANY, LTD. (JP) | 2020-05-12 | — | — | US | disclosed |
| US-20170358399-A1 | TERTIARY AMINE COMPOUND, PHOTOELECTRIC CONVERSION ELEMENT, AND SOLAR CELL | RICOH COMPANY, LTD. (JP) | 2017-12-14 | — | — | US | disclosed |
| US-20170358399-A1 | TERTIARY AMINE COMPOUND, PHOTOELECTRIC CONVERSION ELEMENT, AND SOLAR CELL | RICOH COMPANY, LTD. (JP) | 2017-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170358399-A1 | TERTIARY AMINE COMPOUND, PHOTOELECTRIC CONVERSION ELEMENT, AND SOLAR CELL | SUN2, CRY1, TEAD1 | PYCR1 2553/4885CNR2 1649/4885TSHR 2632/4885 |
| US-10651390-B2 | Tertiary amine compound, photoelectric conversion element, and solar cell | SUN2, CRY1, TEAD1 | PYCR1 2553/4885CNR2 1649/4885TSHR 2632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.